Notably, we conducted a case study ex vivo involving MSS metastatic CRC harboring the POLE A456P exonuclease mutation, along with five additional mutations of unknown significance on the POLE gene (Figure 3). The gene discussed is POLE; the disease is colorectal carcinoma.